Intelligence Platform

Patents

Browse 837 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 7119066

Modified ciliary neurotrophic factor (CNTF)

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087411

Fusion protein capable of binding VEGF

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7070959

Modified chimeric polypeptides with improved pharmacokinetic properties

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7063840

TIE-2 ligands, methods of making and uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 20 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7052695

Angiopoietins and methods of treating hypertension

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7052705

Anti-angiogenic peptides

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7052691

Methods of treating diabetes by blocking VEGF-mediated activity

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7045302

Expressed ligand-vascular intercellular signaling molecule

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7008781

Method of enhancing the biological activity of ligands

REGENERON PHARMACEUTICALS, INC. · Granted Tue Mar 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6958140

Methods of imaging and targeting vasculature

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6933276

Methods of treating peripheral neuropathies using neurotrophin-3

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 23 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6927044

IL-1 receptor based cytokine traps

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 09 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6881395

TIE-2 ligand-4

REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 19 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6852838

Tyrosine kinase receptors and ligands

REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6846914

Tie-2 ligand-3

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6846908

DCR-5 bone affecting ligand

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6833349

Methods of treating inflammatory skin diseases

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 21 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6825008

Expressed ligand—vascular intercellular signalling molecule

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6811780

Methods of using cytokine antagonists to treat HIV infection and AIDS

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6767894

Use of ciliary neurotrophic factor

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 27 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6680291

Modified ciliary neurotrophic factor, method of making and methods of use thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6660499

DCR5, a BMP-binding protein, and applications thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6656474

Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hy

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6645484

Method of blocking blood vessel growth using tie-2 ligand 2

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)